$INTC The current trend is quite interesting. I see that $JPM raised its target price to $85, but still assigned an Underweight rating. Do the math and it’s clear—right now the stock is trading around $100, and their estimated fair value is still about 15% lower. In plain terms, they think this price isn’t cheap.
What really makes me cautious is the “staggered” capital expenditure cycle for $INTC . Management says it’s for long-term agreements and customer prepayments, but analysts out there are generally wondering whether these steps are bigger than the actual market demand. The data makes it more intuitive: for FY26, capital expenditures need to reach more than $20 billion; equipment spending is up 40% year over year; then for CY27, they still plan to push it further to $26 billion.
Now look at cash flow—turning positive in 2027 will be a tough battle. Yes, they still have roughly $30 billion in cash and $10 billion in credit facilities on the books, but capital expenditure is a bottomless pit that won’t be filled. The worst-case scenario is that one day cash gets tight and they do another round of equity financing. The public float is already 5.1 billion shares. If they get diluted again, the profit momentum they’ve worked so hard to build would be diluted directly and shown to existing shareholders.
Valuation also looks like it’s been overhauled. Based on estimated earnings of $3.60 per share in 2028, they assigned a 24x P/E, putting the target price at $85. That sits within the peers’ 20–25x range. It’s a big upgrade compared to the previous $45 at the end of 2026, but the problem is that even after all this, it’s still a 15% discount versus the current price. So unless $INTC can prove that the contract manufacturing business can truly land big orders and become real, tangible revenue—and also that cash-flow pressure eases—then I’m not convinced the premium is warranted.
Of course, it’s not without opportunities. It depends on a few key variables: if the 18A or 14A process truly ramps up faster than expected and technical leadership lands early, then there’s a chance. Also, if the PC and server market deteriorates less than people expect, revenue could grow sooner. And if the contract manufacturing segment can announce a Tier-1 big customer, sentiment could change immediately.
In the end, $INTC is essentially racing against time and capital. The profit potential in DCAI is visible, but the financial burden from the stepwise spending and the dilution risk that could come at any moment is the red line hanging overhead. My stance is very clear—until free cash flow truly turns positive, be cautious and don’t bet real money on a story that hasn’t been fully realized yet. Protecting capital matters more than anything.
What really makes me cautious is the “staggered” capital expenditure cycle for $INTC . Management says it’s for long-term agreements and customer prepayments, but analysts out there are generally wondering whether these steps are bigger than the actual market demand. The data makes it more intuitive: for FY26, capital expenditures need to reach more than $20 billion; equipment spending is up 40% year over year; then for CY27, they still plan to push it further to $26 billion.
Now look at cash flow—turning positive in 2027 will be a tough battle. Yes, they still have roughly $30 billion in cash and $10 billion in credit facilities on the books, but capital expenditure is a bottomless pit that won’t be filled. The worst-case scenario is that one day cash gets tight and they do another round of equity financing. The public float is already 5.1 billion shares. If they get diluted again, the profit momentum they’ve worked so hard to build would be diluted directly and shown to existing shareholders.
Valuation also looks like it’s been overhauled. Based on estimated earnings of $3.60 per share in 2028, they assigned a 24x P/E, putting the target price at $85. That sits within the peers’ 20–25x range. It’s a big upgrade compared to the previous $45 at the end of 2026, but the problem is that even after all this, it’s still a 15% discount versus the current price. So unless $INTC can prove that the contract manufacturing business can truly land big orders and become real, tangible revenue—and also that cash-flow pressure eases—then I’m not convinced the premium is warranted.
Of course, it’s not without opportunities. It depends on a few key variables: if the 18A or 14A process truly ramps up faster than expected and technical leadership lands early, then there’s a chance. Also, if the PC and server market deteriorates less than people expect, revenue could grow sooner. And if the contract manufacturing segment can announce a Tier-1 big customer, sentiment could change immediately.
In the end, $INTC is essentially racing against time and capital. The profit potential in DCAI is visible, but the financial burden from the stepwise spending and the dilution risk that could come at any moment is the red line hanging overhead. My stance is very clear—until free cash flow truly turns positive, be cautious and don’t bet real money on a story that hasn’t been fully realized yet. Protecting capital matters more than anything.